In this session of Partnerships TV, Marc Dresner speaks with Donna Jarlenski, Vice President, Clinical Operations, Momenta Pharmaceuticals. They look at how orphan drugs will affect the drug development landscape.

Partnerships take place every spring. For more information on Partnerships, visit our homepage:
[ Ссылка ]

свернуть